From Patricia.Carroll at utn.org Tue May 9 11:00:52 2017 From: Patricia.Carroll at utn.org (Patricia Carroll) Date: Tue, 9 May 2017 17:00:52 +0000 Subject: [UTN Media] HB345 - Telehealth Pilot Project Grant Pre-announcement Message-ID: Telehealth Pilot Project Grant - https://le.utah.gov/~2017/bills/static/HB0345.html The 2017 Utah Legislature approved $350,000 in one-time funding to the Department of Health - Family Health and Preparedness for telehealth pilot project/s. An official announcement will be made on or before July 1, 2017 that will outline the application process and timeline for proposal submissions for use of this funding. The purpose of the Telehealth Pilot Project Grant is to determine how telehealth services can best be used in the state, to determine the best practices and identify the types of health care services for which telehealth services may be most beneficial. Utah Department of Health - Family Health and Preparedness is looking for innovative telehealth pilot proposals to identify the types of health care services & best practices for providing healthcare services using telehealth. Regards, Patricia Patricia A. Carroll, RN MSN Telehealth Development Manager Utah Education & Telehealth Network 101 Wasatch Drive Salt Lake City, UT 84112 801-587-6075 - w patricia.carroll at utn.org www.utn.org [cid:image001.png at 01D21E26.00B92590] -------------- next part -------------- An HTML attachment was scrubbed... URL: -------------- next part -------------- A non-text attachment was scrubbed... Name: image001.png Type: image/png Size: 15321 bytes Desc: image001.png URL: From Patricia.Carroll at utn.org Mon May 15 13:46:18 2017 From: Patricia.Carroll at utn.org (Patricia Carroll) Date: Mon, 15 May 2017 19:46:18 +0000 Subject: [UTN Media] UAHEC videoconference and live web stream - ANSWERING YOUR QUESTIONS ON VENOUS THROMBOEMBOLISM (VTE), May 17, 2017 12:00 PM - 1:00 PM In-Reply-To: References: Message-ID: ANSWERING YOUR QUESTIONS ON VENOUS THROMBOEMBOLISM (VTE) Live Web Stream on Wednesday, May 17, 2017 12:00 PM - 1:00 PM Faculty Presenter: Katie Traylor, PharmD, BCACP, BC-ADM Assistant Professor, Pharmacotherapy, University of Utah College of Pharmacy Clinical Pharmacist, Madsen Family Clinic, Department of Family and Preventive Medicine This Continuing Education Opportunity is brought to you by:[cid:image001.png at 01D2CD81.A23B5B80][cid:image002.png at 01D2CD81.A23B5B80] [Image result for interstate postgraduate medical association] Registration If you are planning to participate in this free educational activity, please email your name and affiliation to utahahec at utah.edu. The event will be accessible via the following web link: https://uvc.utn.org/videos/reserveurl/3529ea68-660a-11e6-ba74-00000079ba9d. Target Audience This activity was developed for primary care physicians and other healthcare professionals who diagnose and manage long-term therapy for patients at risk for VTE. Overview Answering Your Questions on VTE has been developed as part of the work of the The Evolution of Anticoagulation Management (TEAM) (www.TEAManticoag.com) a strategic, multi-institution educational initiative that is designed to reduce stroke and other complications associated with thrombus formation through effective continuing education that results in optimal anticoagulation management. VTE is the third leading vascular diagnosis after myocardial infarction and stroke, affecting approximately 900,000 people and contributing to 3.2% of cardiovascular-related deaths annually in the United States. Learning Objectives Upon completion of this activity, participants should be better able to: u Define the short-term and long-term goals of anticoagulation for VTE. u Determine the optimal length of therapy based on clinical factors. u Manage anticoagulation around medical procedures and special situations. *A maximum of 1.0 AMA PRA Category 1 Credit(s)(tm) is available for participation in this live activity. Acknowledgement Statement This initiative is supported by an unrestricted educational grant from Bristol-Meyers-Squibb and Pfizer Pharmaceuticals Partnership. -------------- next part -------------- An HTML attachment was scrubbed... URL: -------------- next part -------------- A non-text attachment was scrubbed... Name: image003.png Type: image/png Size: 42933 bytes Desc: image003.png URL: -------------- next part -------------- A non-text attachment was scrubbed... Name: image005.png Type: image/png Size: 57669 bytes Desc: image005.png URL: -------------- next part -------------- A non-text attachment was scrubbed... Name: image007.png Type: image/png Size: 16913 bytes Desc: image007.png URL: -------------- next part -------------- A non-text attachment was scrubbed... Name: image001.png Type: image/png Size: 17941 bytes Desc: image001.png URL: -------------- next part -------------- A non-text attachment was scrubbed... Name: image002.png Type: image/png Size: 15504 bytes Desc: image002.png URL: -------------- next part -------------- A non-text attachment was scrubbed... Name: image009.png Type: image/png Size: 10209 bytes Desc: image009.png URL: -------------- next part -------------- A non-text attachment was scrubbed... Name: Flyer_ANSWERING YOUR QUESTIONS ON VENOUS THROMBOEMBOLISM.docx Type: application/vnd.openxmlformats-officedocument.wordprocessingml.document Size: 138022 bytes Desc: Flyer_ANSWERING YOUR QUESTIONS ON VENOUS THROMBOEMBOLISM.docx URL: -------------- next part -------------- A non-text attachment was scrubbed... Name: Flyer_ANSWERING YOUR QUESTIONS ON VENOUS THROMBOEMBOLISM.pdf Type: application/pdf Size: 314944 bytes Desc: Flyer_ANSWERING YOUR QUESTIONS ON VENOUS THROMBOEMBOLISM.pdf URL: